This is my view on MARKSANS;
CMP 69.85 | T1: 98 (~40%) | T2: 108 (~55%)
The rationale for the going long:
- Stock moves up with high volumes and pullback occur with lower volumes.
- Base formation (consolidation) at 66-69 Levels
- RSI Bullish Divergence.
- Highest revenue and net profits in FY 2021 & TTM QE June 2021 (in past 10years).
- Low PE of ~11 compared to...
DISCLOSURE
This is only for educational purpose
This is not a recommendation
I am not SEBI registered
Do not TRADE/INVEST basis what I publish here
I am not responsible for your loss or gain
It is prudent to assume that I have ulterior motives in publishing this Idea
I and my clients might or might not have a position, I and my clients might or might not...
Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. Its product portfolio spreads over major therapeutic areas such as oncology, gastroenterology, anti-diabetic, cardiovascular, pain management, and gynecology. The company was founded by Mark Bosco Saldanha on April 16, 1992 and is headquartered in Mumbai,...
Stock may find support in 64-56 zone . Expect to be a 3 times + story from this zone. 49 on DCB is stop loss.
Disc : it's not an investment advice to buy or sell
This scrip has formed Descending Triangle and expcted to Give breakout. So traders keep on your radar to catch the momentum and enjoy the profit. Kindly like and share it to all your friends and needy people. Thanks to all.
Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. Its product portfolio spreads over major therapeutic areas such as oncology, gastroenterology, anti-diabetic, cardiovascular, pain management, and gynecology. The company was founded by Mark Bosco Saldanha on April 16, 1992 and is headquartered in Mumbai, India.
NSE
